User login
Diabetes in Special Populations
Article Type
Changed
Display Headline
Diabetes in Special Populations
Diabetes treatment goals include an A1C of less than 7% without inducing hypoglycemia. Now, MEDS faculty member Davida Kruger offers tips on how you can individualize that goal for special populations—such as patients older than 65.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References
Publications
Topics
Legacy Keywords
special populations, diabetes, geriatrics, A1C, treatment, hypoglycemia
Diabetes treatment goals include an A1C of less than 7% without inducing hypoglycemia. Now, MEDS faculty member Davida Kruger offers tips on how you can individualize that goal for special populations—such as patients older than 65.
Diabetes treatment goals include an A1C of less than 7% without inducing hypoglycemia. Now, MEDS faculty member Davida Kruger offers tips on how you can individualize that goal for special populations—such as patients older than 65.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References
References
Publications
Publications
Topics
Article Type
Display Headline
Diabetes in Special Populations
Display Headline
Diabetes in Special Populations
Legacy Keywords
special populations, diabetes, geriatrics, A1C, treatment, hypoglycemia
Legacy Keywords
special populations, diabetes, geriatrics, A1C, treatment, hypoglycemia
Article Source
PURLs Copyright
Inside the Article
Diabetes Meds
Article Type
Changed
Display Headline
Diabetes Meds
Davida Kruger discusses SGLT2 medications—a new class of diabetes drugs—and its mechanism of action and the benefits. Interviewed by Mimi Secor, MS, MEd, APRN, BC, FNP, FAANP
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
To hear her lecture on “Cost-Effective Diabetes Treatment for the Under-Uninsured,” and earn CE/CME credit, please attend the 2013 MEDS West in Irvine, CA, October 3-5. Click here for complete details.
Publications
Topics
Legacy Keywords
diabetes, nutrition, MEDS, medication, insulin, uninsured, cost effective, cheap, alternative
Davida Kruger discusses SGLT2 medications—a new class of diabetes drugs—and its mechanism of action and the benefits. Interviewed by Mimi Secor, MS, MEd, APRN, BC, FNP, FAANP
Davida Kruger discusses SGLT2 medications—a new class of diabetes drugs—and its mechanism of action and the benefits. Interviewed by Mimi Secor, MS, MEd, APRN, BC, FNP, FAANP
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
To hear her lecture on “Cost-Effective Diabetes Treatment for the Under-Uninsured,” and earn CE/CME credit, please attend the 2013 MEDS West in Irvine, CA, October 3-5. Click here for complete details.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
To hear her lecture on “Cost-Effective Diabetes Treatment for the Under-Uninsured,” and earn CE/CME credit, please attend the 2013 MEDS West in Irvine, CA, October 3-5. Click here for complete details.
Publications
Publications
Topics
Article Type
Display Headline
Diabetes Meds
Display Headline
Diabetes Meds
Legacy Keywords
diabetes, nutrition, MEDS, medication, insulin, uninsured, cost effective, cheap, alternative
Legacy Keywords
diabetes, nutrition, MEDS, medication, insulin, uninsured, cost effective, cheap, alternative
Article Source
PURLs Copyright
Inside the Article
